AMENDMENT NO. 1 TO SENIOR CONVERTIBLE NOTESSenior Convertible Notes • October 27th, 2005 • Internet Capital Group Inc • Services-business services, nec • New York
This Amendment No. 1 (this “Amendment”) is effective as of October 18, 2005 to each of the Senior Convertible Notes (collectively, the “Notes”) issued pursuant to that certain Securities Purchase Agreement dated as of March 31, 2004, by and among Internet Capital Group, Inc., a Delaware corporation (the “Company”), and the initial holders of the Notes. All capitalized terms used herein and not otherwise defined herein shall have the meaning attributed to them in the Notes.
AMENDMENT TO SENIOR CONVERTIBLE NOTESSenior Convertible Notes • March 1st, 2024 • Allarity Therapeutics, Inc. • Pharmaceutical preparations
This Amendment to Senior Convertible Notes (this “Amendment”) is made and entered into as of February 27, 2024 (“Effective Date”), by and between Allarity Therapeutics, Inc., a Delaware corporation (the “Company”), and 3i, LP, a Delaware limited partnership (the “Holder”). The Company and the Holder are sometimes hereinafter referred to as the “Parties.”
AMENDMENT NO. 2 TO SENIOR CONVERTIBLE NOTESSenior Convertible Notes • October 27th, 2005 • Internet Capital Group Inc • Services-business services, nec • New York
This Amendment No. 2 (this “Amendment”) is effective as of October 25, 2005 to each of the Senior Convertible Notes (collectively, the “Notes”) issued pursuant to that certain Securities Purchase Agreement dated as of March 31, 2004, by and among Internet Capital Group, Inc., a Delaware corporation (the “Company”), and the initial holders of the Notes. All capitalized terms used herein and not otherwise defined herein shall have the meaning attributed to them in the Notes.
January 7, 1999 To the Holders of the Senior Convertible Notes of NaPro BioTherapeutics, Inc. Gentlemen: Reference is made to (i) the Note Purchase Agreements (as amended by the January Amendment and the March Amendment (each as defined herein), the...Senior Convertible Notes • January 15th, 1999 • Napro Biotherapeutics Inc • Medicinal chemicals & botanical products
AMENDMENT NO. 1 TO SENIOR CONVERTIBLE NOTESSenior Convertible Notes • January 30th, 2024 • Triller Corp. • Services-computer programming, data processing, etc.
THIS AMENDMENT NO. 1 TO SENIOR CONVERTIBLE NOTES (this “Amendment”) is made and entered into as of August 18, 2023 (the “Amendment Date”), by and among Triller Hold Co LLC, a Delaware limited liability company (the “Company”); Triller Corp. f/k/a Triller Inc., a Delaware corporation (the “Surviving Company”); and Total Formation Inc., a BVI corporation (the “Purchaser”). This Amendment amends and modifies that certain (i) Amended and Restated Senior Convertible Note, dated December 31, 2022 (the “Initial Note”), and (ii) Senior Convertible Note, dated December 31, 2022 (the “Bridge Note” and, together with the Initial Note, the “Notes”), which Notes were issued pursuant to that certain Convertible Note Purchase Agreement dated August 18, 2022 (as amended and restated on December 31, 2022, the “Agreement”). Capitalized terms used but not defined in this Amendment shall have the meanings ascribed to them in the Notes. The Company, the Surviving Company and the Purchaser are collectively
